Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo
Top Cited Papers
- 3 February 2007
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 119 (1) , 77-85
- https://doi.org/10.1016/j.jconrel.2007.01.016
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Drug delivery systems for hormone therapyJournal of Controlled Release, 2006
- Pharmaceutical Aspects of Polymeric Nanoparticles for Oral Drug DeliveryJournal of Biomedical Nanotechnology, 2005
- In vitro degradation of nanoparticles prepared from polymers based on dl-lactide, glycolide and poly(ethylene oxide)Journal of Controlled Release, 2004
- The effects of molecular weight and porosity on the degradation and drug release from polyglycolideInternational Journal of Pharmaceutics, 2004
- Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugsAAPS PharmSciTech, 2002
- Controlled release of β-estradiol from PLAGA microparticles:: The effect of organic phase solvent on encapsulation and releaseJournal of Controlled Release, 2000
- Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral doseInternational Journal of Pharmaceutics, 1992
- Estrogen Therapy During MenopauseDrugs, 1990
- Drug Delivery Systems: 3A. Role of Polymers in Drug DeliveryThe Journal of Clinical Pharmacology, 1990
- Microencapsulation using poly(DL-lactic acid) III: Effect of polymer molecular weight on the release kineticsJournal of Microencapsulation, 1990